A comprehensive analysis of the ADAMTS13 cysteine-rich domain identifies a novel functional interaction between ADAMTS13 and VWF.
Introduction
ADAMTS13 is a plasma metalloprotease that proteolytically regulates von Willebrand factor (VWF), a critical mediator of platelet tethering and primary haemostasis.
1 VWF circulates in blood in multimeric forms of highly variable size, ranging from dimers through to species that may exceed 60-mers. 2 The multimeric size of VWF is central to its platelet-tethering function, with larger multimers conferring greater haemostatic potential than smaller forms. 3,4 VWF function is regulated in plasma by ADAMTS13-mediated proteolysis, which under conditions of elevated shear forces, converts VWF into smaller, less haemostatically active fragments. 1 The physiological importance of the ADAMTS13-VWF axis is highlighted by cases of either inherited or acquired ADAMTS13 deficiency, which is associated with lifethreatening thrombotic thrombocytopenic purpura (TTP). 5 Moreover, high VWF and low ADAMTS13 plasma levels are independent risk factors for myocardial infarction and stroke. 6, 7 In free circulation, VWF multimers generally adopt a globular fold that not only shields the plateletbinding site in its A1 domain, but also conceals both the scissile bond and high affinity binding sites for ADAMTS13 within the core of the VWF A2 domain. 8, 9 This makes globular VWF ostensibly unable to bind platelets, and also resistant to ADAMTS13-mediated proteolysis. However, during secretion of VWF from endothelial cells, as well as in other scenarios in which VWF is exposed to high shear stress (including at sites of vessel damage), VWF multimers unravel to expose the A1 domain that can potentiate platelet binding. Platelet capture can be concomitantly controlled through the unfolding of the central A2 domain. 10, 11 This process facilitates the exposure of cryptic binding sites in the VWF A2
domain that enable multiple specific interactions with ADAMTS13. 1 These interactions function like a molecular zipper that presents the Tyr1605-Met1606 scissile bond in VWF to the ADAMTS13 active site. 1 Of the reported binding interactions between the two molecules, the one between the ADAMTS13 spacer domain (involving Arg568, Arg660, Tyr661 Tyr665) and the C-terminus of the VWF A2 domain (involving Glu1660 -Arg1668) is thought to be of highest affinity. [12] [13] [14] [15] [16] [17] This interaction approximates the two molecules, enabling an exosite in the ADAMTS13 Disintegrin-like (Dis) domain (involving Arg349, Leu350, Val352) to interact with residues near the VWF scissile bond (including Asp1614). 17, 18 This positions the scissile bond near the catalytic site, in turn allowing critical low affinity interactions between the ADAMTS13 metalloprotease (MP) domain and the P3 residue of VWF (Leu1603) that precede accommodation of the P1-P1' residues in VWF (Tyr1605-Met1606) into the S1 and S1' pockets. [19] [20] [21] The importance of the multiple exosites of ADAMTS13 in VWF proteolysis is exemplified by the finding that the MP domain alone cannot cleave VWF specifically. However, addition of the domains C-terminal to the MP domain progressively increases the efficiency of substrate proteolysis. 18, 22, 23 Whereas functional contributions of the MP, Dis and spacer domains to VWF proteolysis have been characterised, questions
remain regarding the precise role that the Cys-rich domain fulfils. Based on the crystal structure of the ADAMTS13 Dis to spacer fragment (termed DTCS) and models of the MP domain, in conjunction with knowledge of the location of VWF binding sites in the MP, Dis and spacer domains ( Supplementary Fig   1) , the Cys-rich domain, particularly the surface of the domain that is located between the Dis and spacer domain exosites, is well situated to interact directly with VWF and to contribute to substrate proteolysis. 1, 17 In support of this contention are the findings by Gao et al, who compared the activities of C-terminally truncated ADAMTS13 mutants with and without the Cys-rich domain (termed MDTC and
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Methods

Expression of recombinant ADAMTS13 Cys-rich domain variants
The wild-type (WT) human ADAMTS13 mammalian expression vector that fuses a myc-His tag to the Cterminal has been described previously. 24 Single point and composite mutants (R452A, D454A, R459A, H476A, H476A/Q478A, D480A, R484A, I490A, E492A, K497A, D500A) and introduction of the N-linked glycan attachment motif mutants: G464N (Gly1), H469N/G471T (Gly2), H476N/Q478T (Gly3), S493N/I495T (Gly4), S511N/P513T (Gly5), Q539N/V541T (Gly6) was performed using KOD polymerase (Merck). ADAMTS13 Cys-rich domain swap variants in which specific sequences were replaced by the corresponding sequences from ADAMTS1 were also generated by PCR, including, Phe445-Ser501 (Cys
Gly471-Gln478 (Cys4), Gly471-Val474 (Cys5) and Pro475-Gln478 (Cys6) (Fig 1) .
ADAMTS13 and ADAMTS13 variants were transiently expressed in HEK293T in OptiMEM (Invitrogen).
After 3 days, conditioned medium was harvested and concentrated ten-fold using 50kDa MWCO centrifugal filter units (Millipore). Expression and secretion were analysed by Western blotting using an anti-myc Ab (Santa Cruz) or biotinylated polyclonal anti-ADAMTS13 TSP(2-4) for detection. To assess successful addition of a novel glycan for the Gly1-6 mutants, conditioned medium was first treated with 350nM thrombin (Enzyme Research Laboratories) overnight, and the cleavage fragment Ser394-Arg910 was detected by Western blot with biotinylated polyclonal anti-ADAMTS13 TSP(2-4). The concentrations of ADAMTS13 and its variants were measured by ELISA, as previously described.
25
Expression and purification of VWF115, VWF115 mutants and VWF106.
Recombinant VWF A2 domain fragments, VWF115 (VWF residues 1554-1668) 26 and its C-terminally truncated variant VWF106 (residues 1554-1659) 14 were used as substrates for ADAMTS13, and also to measure ADAMTS13 binding. VWF115 and VWF106 both contain an N-terminal 6xHis and Xpress epitope tag. They were expressed in Rosetta DE-3 E.Coli (Novagen), purified and quantified as described previously.
26
The mutations I1649S/L1650S/I1651S, termed 3S, and I1642S/W1644S/I1649S/L1650S/I1651S, termed 5S, were introduced by site-directed mutagenesis using KOD Hot-Start polymerase (Merck) and confirmed by sequencing.
ADAMTS13 activity assays
ADAMTS13 activity was analysed using VWF115 or VWF115 3S and 5S variants as a substrate as previously described. 18 As indicated, 1-45 nM ADAMTS13 or ADAMTS13 variant in concentrated conditioned media was pre-incubated with 5mM CaCl 2 for 1 hr before addition of 6µM VWF115 or
For personal use only. on April 12, 2017. by guest www.bloodjournal.org From VWF115 variant (both final concentrations) to start the reaction. Subsamples were removed from 0 to 2 hr time points, stopped with EDTA and proteolysis analysed qualitatively by SDS-PAGE and Coomassie staining. All assays were repeated at least 3 times and representative gels are shown. To derive k cat /K m for VWF115(5S), activity assays were carried out as above, except that 1 µM substrate was used and proteolysis was quantified by densitometry (ImageJ) of Western Blots using an anti-Xpress antibody (Life Tech). Time-course reaction curves (n = 3-6) were plotted using Graphpad Prism and k cat /K m derived as described previously.
26
When the fluorogenic substrate, FRETS-VWF73, was used, 100µl WT ADAMTS13 or ADAMTS13 variants in conditioned medium diluted to 0.6nM in assay buffer (20mM Tris, 25 mM CaCl 2 , and 0.005%
Tween-20 at pH 7.5) was added to a white 96-well plate. 100µl FRETS-VWF73 substrate was added to each well to start the reaction (final concentration of 1µM). Fluorescence (excitation 340 nm; emission 460 nm) was measured at 37°C at 90 seconds intervals for 1 hour using a Fluostar Omega plate reader (BMG Labtech). To derive k cat /K m , assays were repeated as above except that ADAMTS13 and ADAMTS13 variant concentrations were adjusted for each mutant to enable complete proteolysis to occur within 90 mins.
Plate binding assays
Binding of ADAMTS13 and ADAMTS13 variants to immobilised recombinant VWF115 was analysed as described previously.
27 Briefly, purified VWF115 or VWF115 3S, 5S variants were diluted to 50 or 100 nM (as indicated) in 50mM sodium carbonate buffer (pH 9.6) and immobilised onto a 96-well plate overnight at 4°C. After washing and blocking the wells with PBS/0.1% Tween and PBS/3% BSA, respectively, 100 µl of 0 to 200nM WT ADAMTS13 or ADAMTS13 variant diluted in 1% BSA/30mM
EDTA/PBS was added to wells and incubated for 2 hr. Thereafter, wells were washed and biotinylated anti-ADAMTS13 TSP(2-4) antibody and streptavidin-HRP used for detection. Equal coating of VWF115 and VWF115 mutants was confirmed using a mouse monoclonal Ab that detects the Xpress tag that is fused to VWF115.
Results
Sequence analysis of ADAMTS13 Cys-rich domain
Based upon amino acid sequence alignments, the Cys-rich domain contains a conserved region (spanning Phe502 to Cys555) that is broadly conserved among ADAMTS family members ( Supplementary Fig 2) . This conservation points to a structural role for this region in the global fold of the domain. Consistent with this contention, this conserved region sits between the adjacent TSP1 and spacer domains in the crystal structure of these domains and is not exposed to the substrate-binding face of the protease. There is also a non-conserved region in the Cys-rich domain (spanning Ala451 to Ser501) with much higher sequence variability amongst ADAMTS family members, suggesting that this region may be involved in enzyme-specific functions. As this non-conserved Cys-rich region is located on the VWF-binding face of ADAMTS13, we hypothesised that it may contribute specifically to ADAMTS13 function. 
Targeted mutagenesis of the ADAMTS13 Cys-rich domain
We first targeted the non-conserved region in the ADAMTS13 Cys-rich domain by site-directed mutagenesis ( Fig 1A&B and Supplemental Fig 2) . Eleven predominantly charged and surface exposed amino acids in this non-conserved region were mutated to alanine (Fig 1B & Supplementary Fig 2) . All mutants were expressed and secreted normally. To assess the influence of these substitutions on ADAMTS13 function, we assayed their activity using VWF115 as a substrate. These results revealed that all ADAMTS13 mutants cleaved VWF115 with similar efficiency to WT ADAMTS13 (Fig 2A) , suggesting that none of the mutated residues have a major influence on VWF proteolysis, or form part of any important functional exosite in ADAMTS13.
Engineering novel N-linked glycans into ADAMTS13 identifies a functional region within the Cysrich domain
As a further search for functionally important sites, we screened larger areas of the Cys-rich domain through the introduction of N-linked glycan attachment motifs (N-X-S/T) by site-directed mutagenesis ( Fig 1B & Supplemental Fig 2) . As N-linked glycans are ~5kDa and have a diameter of ~30Å they have the potential to disrupt interactions in the vicinity of the attachment site. We designed eight mutants carrying a new NXS/T motif at various sites in the Cys-rich domain predicted to be located on the surface of the domain. All were expressed and secreted efficiently. Of the eight variants, we confirmed addition of a new glycan in six of these, as visualised by a band shift in a Western blot of conditioned media ( Supplementary Fig 3) . We assessed the ability of these six ADAMTS13 glycan mutants (termed Gly1-6) to cleave VWF115. All variants proteolysed VWF115 efficiently, except Gly3 (H476N/Q478T) for which greatly reduced proteolysis was observed (Fig 2B) . This suggests that the new glycan at position 476 disrupts a functionally important interaction between ADAMTS13 and VWF, or obstructs the path of VWF between interaction sites on ADAMTS13. This effect was very likely attributable to the insertion of a new glycan, as when H476 and Q478 were substituted to alanine, there was no effect upon VWF115 proteolysis (not shown).
ADAMTS13 Cys-rich domain swap variants identify Gly471-Val474 as important to ADAMTS13 function
The next approach that we used to identify functionally important sites involved swapping selected sequences in the non-conserved region in the ADAMTS13 Cys-rich domain with the corresponding sequence in ADAMTS1 (Fig 1C) . Of the nine swap variants that were made, six (termed Cys1-6) were secreted efficiently and therefore analysed functionally. In the ADAMTS13 Cys1 variant, Phe445-Ser501 was replaced, which spans the entire non-conserved region. Using 5nM WT ADAMTS13, VWF115 proteolysis went to completion in <30 mins. However, under these same conditions, the proteolysis of VWF115 by the Cys1 variant was appreciably reduced ( Fig 3A) and even after 90 mins VWF115 was still only partially proteolysed. This suggests that the non-conserved region within the ADAMTS13 Cys-rich domain is of functional importance for ADAMTS13.
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The ADAMTS13 Cys2 variant, in which Gln456-Gln478 was replaced, was analysed under slightly different conditions. Using 2nM WT ADAMTS13 proteolysis of VWF115 was almost complete after 45 mins, whereas the Cys2 variant was still only partially proteolysed after 120 mins ( Fig 3B) . Interestingly, this region of twenty-three amino acids contains the site where the glycan is attached in the Gly3 variant.
The ADAMTS13 variant, Cys3 (Ala465-Trp470) proteolysed VWF115 near normally, whereas variant Cys4 (Gly471-Gln478) had a functional deficit similar to Cys2 (Fig 3B) . Finally, we generated two further ADAMTS13 variants, Cys5 and Cys6, in which Gly471-Val474 and Pro475-Gln478, respectively, were replaced. Proteolysis of VWF115 by variant Cys6 was minimally affected (Fig 3C) , suggesting that the residues Pro475-Gln478 are not of major importance. Conversely the Cys5 variant, exhibited a reduced rate of VWF115 proteolysis similar to Cys1, 2 and 4, suggesting that it is substitution of this 4 amino acid region that is responsible for the reduced activity ( Fig 3C) .
To confirm and quantify the reductions in activity of the Cys5 and the Gly3 variants, we used the fluorogenic ADAMTS13 substrate FRETS-VWF73 ( Fig 4A & Table 1 ). This revealed that the k cat /K m for the proteolysis of FRETS-VWF73 by WT ADAMTS13 (9.1 ± 1.5 x10 5 M -1 s -1
) was very similar to previous reports 13, 15, 23 . By comparison, the k cat /K m for ADAMTS13 Cys5 was reduced 6-fold (1.5 ± 0.4 x10 5 M -1 s -1 ), whereas the ADAMTS13 Gly3 mutant exhibited an 11-fold (0. When compared to the 6-fold reduction of the Cys5 variant, this provides an indication of the relative importance of the exosites that are disrupted in the Cys5 and Gly3 variants.
As VWF73 and VWF115 are short VWF A2 domain fragments, their proteolysis by ADAMTS13 may not be truly reflective of the cleavage of full-length VWF multimers. We therefore compared the ability of WT ADAMTS13 and the ADAMTS13 Cys5 and Gly3 variants to cleave full length VWF and visualised proteolysis by Western blot under reducing conditions. Because the chaotropic reagents that are commonly used to unfold VWF in vitro under static conditions disrupt hydrophobic interactions 28 and may interfere with Cys-rich domain binding to VWF, we used a recombinant VWF variant (N1602A/C1669G/C1670G) that is cleaved efficiently in the absence of denaturants due to mutation of both the A2 domain Ca 2+ -binding site and the two vicinal cysteines at the C-terminal end of the A2 domain. 29 . This full length VWF variant was rapidly cleaved in the presence of 8 nM WT ADAMTS13 and approached completion after 45 mins (Fig 4B) , whereas only limited proteolysis was seen at this time for the ADAMTS13 variants Cys5, Gly3 and RRYY, confirming the reduced activity of these ADAMTS13
variants seen when short substrates VWF73 and VWF115 were used.
ADAMTS13 Cys-rich domain variants exhibit reduced VWF binding
To explore the mechanism underlying the reduced activity of the ADAMTS13 Gly3 and Cys5 variants, we analysed the binding affinity of ADAMTS13 Gly3, Cys5 and Cys6 for VWF115 using a plate binding assay. Using this approach, WT ADAMTS13 bound VWF115 with low nanomolar affinity (Fig 4C) K D values for these interactions was not possible due to the large reduction in binding, which did not approach saturation. This assay monitors the tight binding interaction between ADAMTS13 and the unravelled VWF A2 domain and has previously been considered to be highly dependent upon the ADAMTS13 spacer domain. This contention was further corroborated by the marked reduction in VWF115 binding by the spacer domain variant RRYY.
Identification of hydrophobic VWF A2 domain residues that contribute to ADAMTS13 binding
Inspection of the crystal structure of the ADAMTS13 Cys-rich domain (PDB ID: 3GHM) 17 suggested that a hydrophobic pocket in the Cys-rich domain (involving Ala472, Ala473, Val474) may have been disrupted in the Cys5 variant that might represent a distinct exosite to that in the spacer domain, or alternatively may be a part of an extended exosite that includes the spacer domain. To examine this further, we analysed the proteolysis of VWF106, a recombinant VWF A2 domain fragment identical to VWF115, but that lacks the 9 C-terminal amino acids previously reported to be essential for spacer domain binding. Proteolysis of this substrate is appreciably less efficient than that of VWF115.
Consequently, we used 17nM ADAMTS13 in these reactions. Under these conditions, VWF106 was almost completely proteolysed after 60 mins ( Fig 5A) . The Cys5 variant still exhibited a proteolytic deficit suggesting that the effect of the substitutions in Cys5 may be distinct from the function of the spacer domain ( Fig 5A) .
Gao et al previously reported that VWF A2 domain residues Gln1624-Arg1641 can be deleted from short A2 domain fragment substrates without a major reduction in the rate of proteolysis by ADAMTS13 23 . This prompted us to search VWF residues Ile1642-Arg1659 for a complementary hydrophobic exosite that might interact with the ADAMTS13 Cys-rich domain. Within this VWF region, there are several hydrophobic residues that could potentially mediate a hydrophobic interaction with ADAMTS13
( Supplementary Fig 1) . To investigate this, we generated and expressed the composite mutants
VWF115(3S) (I1649S/L1650S/I1651S) and VWF115(5S) (I1642S/W1644S/I1649S/L1650S/I1651S) in
which clusters of these hydrophobic residues were substituted for serine. We purified and quantified these composite mutants and analysed their proteolysis by ADAMTS13. Interestingly, using 1nM WT ADAMTS13, VWF115 was proteolysed to completion after 60 mins, whereas VWF115(3S) was cleaved appreciably slower and VWF115(5S) was cleaved even less efficiently, with the majority of each substrate remaining uncleaved even after 3 hours (Fig 5B) . To quantify proteolysis of VWF115 and VWF115(5S), ADAMTS13 concentration was titrated for each substrate to identify a concentration at which proteolysis reached completion within 90 mins [2.5nM for VWF115, 24nM for VWF115(5S)]. The k cat /K m was derived from time course curves ( Supplementary Fig 4) . However, the k cat /K m for VWF115(5S) proteolysis was reduced 12-fold (0.26 ±0.07
The reduced proteolysis of the VWF115(3S) and (5S) mutants is accompanied by a marked effect on ADAMTS13 binding, as determined using the plate binding assay (Fig 5C) . WT ADAMTS13 bound to
For personal use only. on April 12, 2017. by guest www.bloodjournal.org From VWF115 with high affinity, as before. The binding of ADAMTS13 to VWF115(3S) was markedly reduced and to VWF(5S) was even further reduced. Again, derivation of K D values for the interaction of WT ADAMTS13 with VWF115(3S) and (5S) was not possible. These results suggest that the five hydrophobic VWF residues Ile1642, Trp1644 Ile1649, Leu1650 and Ile1651 are involved in hydrophobic interactions between ADAMTS13 and VWF.
As these hydrophobic VWF residues are in a region that has previously been proposed to interact with the ADAMTS13 Cys-rich domain, and the finding that residues Gly471-Val474 within the Cys-rich domain may form a hydrophobic pocket that is critical for ADAMTS13 activity, we hypothesised that these ADAMTS13 and VWF residues are involved in complementary hydrophobic interactions. To examine this, we compared the proteolysis of VWF115(3S) and VWF115(5S) by WT ADAMTS13 and ADAMTS13 Cys5. Interestingly, VWF115(3S) and VWF115(5S) were proteolysed at very similar rates by both WT and Cys5 (Fig 5D-E and Supplementary Fig 4) and ADAMTS13 Cys5 was lost using VWF115(3S) or VWF115(5S) this implies that the deficit in Cys5 is dependent upon VWF residues Ile1642, Trp1644 Ile1649, Leu1650 and Ile1651.
Discussion
The MP domain of ADAMTS13 requires VWF binding exosites in the other domains to enable its proteolysis of VWF. The two exosites that have been reported by multiple research groups involve 1) the ADAMTS13 Dis domain residues Arg349 and Leu350 17,18 and 2) the ADAMTS13 spacer domain residues Arg568, Arg660, Tyr661 and Tyr665. 14, 15, 17 The distance between these two exosites is more than 100 Å in the crystal structure of ADAMTS13 DTCS, which has raised the question of whether there are additional exosites in the intervening TSP-1 or Cys-rich domains. Although previous reports have suggested that the Cys-rich domain directly interacts with VWF, 17, 22, 23 this is the first comprehensive analysis of this domain that identifies its functional importance.
The results of our analysis support an important contribution of the ADAMTS13 Cys-rich domain to VWF binding and proteolysis. We show that out of six engineered glycans at various positions on the surface of the Cys-rich domain, only one affected VWF binding and proteolysis. The position of this glycan (residue 476) gives an indication of how the unravelled VWF A2 domain bridges the two known exosites in the spacer and Dis domains. Our initial alanine scanning of the Cys-rich domain did not identify any amino acids that are critical for efficient proteolysis of VWF. However, this approach was limited to charged residues and, therefore, hydrophobic residues were not investigated. Our subsequent screening using sequence swap variants suggested a functional role for amino acids located in a hydrophobic pocket comprising amino acids Gly471-Val474 (Fig 6) . This pocket is situated on the same face as the Spacer domain exosite (Fig 6) and in the vicinity of the attachment site of the engineered glycan (Gly3) that also dramatically reduced VWF binding (Fig 4A) .
Physiologically, the proteolysis of VWF by ADAMTS13 requires VWF to unfold in response to elevated shear stress in the circulation, as the binding sites for ADAMTS13, as well as the scissile bond itself, are otherwise not solvent exposed. A consequence of VWF unfolding is the exposure of hydrophobic
Ile1651) contribute to ADAMTS13 binding, as mutagenesis to serine in VWF115(3S) and VFW115(5S) resulted in appreciably reduced binding and proteolysis. These hydrophobic VWF residues may directly interact with the hydrophobic pocket in the ADAMTS13 Cys-rich domain. This contention was supported by the finding that whereas the Cys5 mutant cleaved VWF115 poorly compared to WT ADAMTS13, it cleaved the VFW115(5S) mutant at a similar rate as WT ADAMTS13 (Fig 5D) , suggesting that the functional deficit is dependent on these hydrophobic VWF residues.
By truncating VWF substrates as well as making internal deletions, Gao et al previously showed that VWF residues located within Ile1642-Arg1659 and Glu1660-Arg1668 are necessary for efficient proteolysis, the contribution of Glu1660-Arg1668 being dependent on the spacer domain.
23 Wu et al demonstrated that individual mutagenesis of the six charged residues within the region Ile1642-Arg1668, resulted in a 2-fold reduction in proteolysis for two of the six residues, whereas there was no effect for the other four. 16 These two charged residues therefore fail to account for the reported 75-200 fold reduction in proteolysis when the whole region was deleted. Based on our results, we propose that hydrophobic binding interactions may represent an important component of this region's interaction with ADAMTS13.
Gao et al have also shown that when the region Gln1624-Arg1641 is deleted from VWF73, it does not appreciably alter the rate of proteolysis. 23 In this deletion mutant the maximal distance between Asp1614, which interacts with Arg349 in the Dis domain of ADAMTS13, and Ile1649 is ~87Å, i.e. when this VWF fragment is fully extended. From this we can conclude that any ADAMTS13 residues that may bind to Ile1649, Leu1650 and Ile1651 should be located within 87Å of Arg349, which most Cys-rich domain residues are in the crystal structure of ADAMTS13 DTCS, but spacer domain exosite residues are not.
The functionally important Cys-rich residues that we identified (Gly471-Val474) lie in proximity to residues that have previously been reported to be important for efficient proteolysis of VWF, including Pro475. 17, 31 The East Asian specific polymorphism P475S causes an approximately 16% reduction in plasma activity, which is consistent with the functional importance of the adjacent Gly471-Val474.
Another interesting aspect of our results is that for our ADAMTS13 variant in which Gly471-Val474 was . In WT ADAMTS13 this auto-inhibition appears to be disrupted by conformational changes that occur upon binding to globular VWF. Whether the C-terminal domains also interfere with binding of the Cys-rich domain to VWF is unknown 33, 34 .
In summary, our results demonstrate an important role for the Cys-rich domain in VWF proteolysis and identify hydrophobic residues in both ADAMTS13 and VWF that are critical for efficient proteolysis.
These findings are in agreement with previous findings that suggested the presence of extensive 
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For personal use only. on April 12, 2017. by guest www.bloodjournal.org From For personal use only. on April 12, 2017. by guest www.bloodjournal.org From Reactions were performed at different enzyme concentrations for each variant and each reaction followed to completion. The amino acids sequence of the Cys-rich domain contains a region that is highly conserved among ADAMTS family members (highlighted in grey) and a non-conserved region (indicated). In the non-conserved region, charged amino acids were individually mutated to alanine (bold and larger font). Amino acids that were mutated to asparagine for the introduction of an NXT glycosylation motif are indicated (Gly1-6). () -see Supplementary Fig 2 for location of each variant on a model of ADAMTS13. C) Cys-rich domain sequence swap variants were generated by substitution of selected sequences for the corresponding sequence in ADAMTS1. Variants named Cys1-6 were used for functional analysis. Those swap variants labelled # were generated and expressed, but were not secreted. For personal use only. on April 12, 2017. by guest www.bloodjournal.org From Figure 5 : Identification of hydrophobic VWF A2 domain residues that contribute to ADAMTS13 binding. (A) 6µM VWF106 (Glu1554-Arg1659) was incubated with WT ADAMTS13 or ADAMTS13 Cys5 (17nM) in conditioned medium and aliquots taken at the indicated time points were analysed by SDS-PAGE and Coomassie staining. (B) VWF115(3S) and VWF115(5S) containing composite mutations of hydrophobic residues to serine were used in functional analyses as in A except that 1nM WT ADAMTS13 was used. (C) Binding of WT ADAMTS13 to VWF115(3S) and (5S). VWF115 or variant (100nM) was immobilised on microtitre wells and binding was assessed as in Figure 17 and a homology model of MP-Dis. Surface representation is depicted and colour coded -MP (red), Dis (yellow), TSP1 (green), Cys-rich (blue) and spacer (pink). The bottom figure has been rotated ~90° compared to the top figure. The active site, Dis exosite (R349 and L350) and spacer exosite (R660, Y661 and Y665) are shown in dark red and labelled. A cartoon representation of unravelled VWF A2 domain (dashed blue ribbon) is shown to indicate how we hypothesise it extends across the ADAMTS13 active site and the exosites in the ancillary Dis, Cys-rich and spacer domains, based on the results of mutagenesis studies. The location of the hydrophobic pocket in the Cys-rich domain involving A472, A473 and V474 is shown in red. The position of the novel glycan attachment site that impairs VWF proteolysis (Gly3) is shown in purple. In dark green is the location of the Gly2 variant glycan attachment site that had no effect upon proteolysis.
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